Healthy men help test if new drug changes how body handles common medicines
NCT ID NCT07158398
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a drug called vimseltinib affects two important proteins (BCRP and OATP1B1) that help move medicines in the body. Twenty healthy men took rosuvastatin, a common cholesterol drug, with and without vimseltinib to see if vimseltinib changes how much rosuvastatin gets into the blood. The goal was to understand potential drug interactions, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dr. Vince Clinical Research
Overland Park, Kansas, 66212, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can a new injection help tackle obesity? a safety trial begins
- Will a new pill formula absorb the same? a trial puts it to the test
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could sitting too much alter your nervous system?
- Could a cancer drug alter Metformin's effects? a trial investigates